Study to Confirm the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis

Condition:   Erosive Esophagitis Interventions:   Drug: CJ-12420 100mg QD;   Drug: Esomeprazole 40mg;   Drug: CJ-12420 50mg QD Sponsor:   CJ HealthCare Corporation Recruiting - verified December 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials